ArticlePloS one2026
Prevalence of cancer related fatigue and its associated factors among adult cancer patients in eastern Ethiopia: A cross-sectional study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFatigue is a frequent and distressing symptom experienced by patients with cancer. It may result from the disease process and/or its aggressive treatment, which substantially impact the quality of life of cancer patients. Furthermore, there is a paucity of evidence in the Eastern part of Ethiopia. Hence this study aimed to assess the prevalence of cancer related fatigue and its associated factors among adult cancer patients, Eastern Ethiopia.
methodsHospital based cross-sectional study was conducted from 1st May to 30th August, 2023 among 422 systematically selected cancer patients. Data were collected using structured, interviewer administered questionnaire. The outcome variable was evaluated using the Brief Fatigue Inventory (BFI). Binary logistic regression analyses were performed to examine the association between the explanatory variables and the outcome variable. Adjusted Odds Ratio (AOR) with 95% Confidence Interval (CI) at a P value less 0.05 was used to declare statistically significant association.
resultsOut of 422, 382 individuals with various cancer types participated in the study with a response rate of 90.5%. The prevalence of cancer related fatigue was found to be 71.2% (95%CI: 65.7-75.5). Rural residence (AOR = 2.84, 95%CI: 1.25-6.43), female sex (AOR = 3.25, 95%CI: 1.49-7.0), private occupational status (AOR = 6.44, 95%CI: 2.42-17.12), never used coffee (AOR = 7.02, 95%CI: 2.37-20.75), inpatient admission (AOR = 4.68,95%CI: 2.21-9.88) and advanced (AOR = 6.21, 95%CI: 2.61-14.78) & unclassified cancer stages (AOR = 4.84, 95%CI: 1.42-16.57) were significantly associated with cancer related fatigue.
conclusionsNearly three out of four cancer patients in Eastern Ethiopia experienced cancer related fatigue. The findings highlight the need for a supportive care service including psychosocial counseling and targeted intervention for high risk groups such as female, rural residents, inpatients, private workers and advanced cancer patients. Further research is warranted to explore the protective role of coffee consumption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.